Rakova, J., Truxova, I., Holicek, P., Salek, C., Hensler, M., Kasikova, L., . . . Fucikova, J. (2021). TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients. Oncoimmunology.
Citação norma ChicagoRakova, Jana, et al. "TIM-3 Levels Correlate With Enhanced NK Cell Cytotoxicity and Improved Clinical Outcome in AML Patients." Oncoimmunology 2021.
Citação norma MLARakova, Jana, et al. "TIM-3 Levels Correlate With Enhanced NK Cell Cytotoxicity and Improved Clinical Outcome in AML Patients." Oncoimmunology 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.